21st Aug 2006 07:01
Skyepharma PLC21 August 2006 For Immediate Release 21 August 2006 Appointment of Auditor LONDON, UK, 21 August 2006 - SkyePharma PLC (LSE: SKP; NASDAQ:SKYE) announcesthat Ernst & Young LLP has been selected as the Company's auditor. The newauditor will be responsible for reviewing the Company's unaudited interimresults for the six months ended 30 June 2006, to be announced in lateSeptember. For further information please contact: SkyePharma PLC +44 207 491 1777Peter Laing, Director of Corporate Communications +44 207 491 5124Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court / Rebecca Skye Dietrich About SkyePharma SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now twelve approved products incorporating SkyePharma'stechnologies in the areas of oral, injectable, inhaled and topical delivery,supported by advanced solubilisation capabilities. For more information, visitwww.skyepharma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L